The iMednet eClinical platform offers a cost-effective solution with a full suite of native tools to simplify and shorten study build times, increase efficiency in study execution, and minimize costs through the duration of the study.
The Pandemic Push: Driving Disruption and Lasting Transformation in Clinical Trial Management Mednet and MedTrials recently partnered on a webinar panel to discuss how the COVID-19 pandemic forced and accelerated…
Read More >
Next week, life sciences professionals from around the globe will attend the DIA’s first Virtual Annual Meeting. The panel sessions, presentations and exhibitors will still “convene” for scientific and technological…
Read More >
Join us for a webinar presented by Mednet and MedTrials, Inc. The Pandemic Push: Driving Disruption and Lasting Transformation in Clinical Trial Management Tuesday, June 9 at 1:00 p.m. ET…
Read More >
As many of us continue to adapt to a world that is dramatically different than it was just a few months ago, we are also seeing the profound impact that…
Read More >
The rapid and continual change happening in clinical research can make it very hard to maintain organizational knowledge. Clinical trial teams are faced with a constant influx of information and…
Read More >
Contents: Introduction For clinical trial sponsors, assessing options in the global eClinical solutions market can be an overwhelming task. Emerging technologies, evolving standards, and increasingly complex clinical trial designs all…
Read More >
The COVID-19 pandemic continues to impact our lives in many ways, and the clinical research industry is no exception. Clinical research and the potential for improving health and delivering life…
Read More >
In the past several weeks, much has changed for all of us. The COVID-19 pandemic and social distancing guidelines are adding new pressures across all aspects of our lives, and…
Read More >
This is the third installment of a three-part blog series on Complex Innovative Trial Designs. As we’ve discussed previously, clinical trials are evolving rapidly, with new data sources and medical…
Read More >
As discussed in our last blog, with advances in medical science and new data sources, study design complexity is on the rise. The US FDA continues to show interest and…
Read More >
